cause liver cirrhosis and hepatocellular carcinoma. Silibinin is a constituent of an extract of
milk thistle, which is empirically used as a herbal medicine for the protection of liver, but its
detailed effects on HBV are unknown. Because a previous study reported that silibinin
hinders clathlin-mediated endocytosis (CME), we aimed to test whether silibinin inhibits the
entry of HBV into hepatocytes. Using HepG2-NTCP-C4 cells, which overexpress sodium …